Work

Phase I Trial of Recombinant Human Macrophage Colony-Stimulating Factor Administered by Continuous Intravenous Infusion in Patients With Metastatic Cancer

Year: 1994

Type: article

Study design: Clinical Trial

Source: JNCI Journal of the National Cancer Institute

DOI: 10.1093/jnci/86.1.39

Authors: D. J. Cole, M. G. Sanda, J. C. Yang, D. J. Schwartzentruber, J. Weber, S. E. Ettinghausen, B. A. Pockaj, H. I. Kim, R. D. Levin, H. W. Pogrebniak, J. Balkissoon, R. M. Fenton, L. R. DeBarge, J. Kaye, S. A. Rosenberg, D. R. Parkinson

Institutions: National Institutes of Health, National Cancer Institute, National Eye Institute, Pfizer (United States)

Language: English

Topic: Immune cells in cancer

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2078230889

FWCI: 1.061

Cites:

Cited by: 33

Related to: 10